A Transmission-Blocking Vaccine To Prevent Toxoplasmosis
Funder
National Health and Medical Research Council
Funding Amount
$850,225.00
Summary
Toxoplasma gondii causes a globally important zoonotic disease. It is transmitted by cats, and finds its way into our food chain via infected meat and contaminated water. We have used a unique functional genomics pipeline to discover proteins crucial for reproduction of Toxoplasma in the cat. We will now test combinations of these proteins to immunise cats and prove that we can develop a vaccine that blocks transmission of this highly significant parasitic disease.
Griseofulvin, A Novel Host-directed Antimalarial Drug
Funder
National Health and Medical Research Council
Funding Amount
$461,551.00
Summary
This grant is for a Phase II clinical trial to test an FDA & TGA approved drug for a new use as an antimalarial drug. The parasite uses an enzyme from the human RBC to help it replicate & early trials show this drug appears to disrupt the life cycle of the parasite. This Phase II clinical trial will test the drug on human subjects, & if successful, the drug will be a new and novel way in which to treat and prevent malarial infections in humans.
Discovery Early Career Researcher Award - Grant ID: DE120101529
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Transmission dynamics modelling of zoonotic neglected tropical diseases. This project will develop mathematical models to simulate zoonotic disease transmission and control. Results will provide novel insight for policy makers into effective interventions for schistosomiasis, echinococcosis and clonorchiasis, as well as provide a methodological platform for adaptation to other zoonotic emerging and re-emerging diseases.
A novel approach for controlling insect vectors of human disease. Insects are responsible for transmitting a wide variety of debilitating human diseases such as malaria, dengue and yellow fever. Unfortunately, there are very few options available for controlling these insect pests. This project will develop a novel, eco-friendly approach for control of mosquitoes and other important disease vectors.